Published guidance, NICE advice and quality standards

Showing 691 to 700 of 771

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer	TA212	15 December 2010	15 December 2010
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer	TA208	24 November 2010	24 November 2010
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours	TA209	24 November 2010	24 November 2010
Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours	TA86	27 October 2004	1 November 2010
Denosumab for the prevention of osteoporotic fractures in postmenopausal women	TA204	27 October 2010	27 October 2010
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)	TA206	27 October 2010	27 October 2010
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)	TA207	27 October 2010	27 October 2010
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C	TA200	22 September 2010	22 September 2010
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis	TA199	25 August 2010	25 August 2010